About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- Carbidopa / levodopa
- Procedure number
- PSUSA/00000548/202210
- Regulatory outcome
- Variation
Documents
Carbidopa / levodopa : List of nationally authorised medicinal products - PSUSA/00000548/202210
English (EN) (260.47 KB - PDF)
Carbidopa / levodopa : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00000548/202210
English (EN) (136.61 KB - PDF)
български (BG) (114.15 KB - PDF)
español (ES) (122.87 KB - PDF)
čeština (CS) (121.33 KB - PDF)
dansk (DA) (154 KB - PDF)
Deutsch (DE) (142.78 KB - PDF)
eesti keel (ET) (147.98 KB - PDF)
ελληνικά (EL) (167.01 KB - PDF)
français (FR) (113.54 KB - PDF)
hrvatski (HR) (214.64 KB - PDF)
íslenska (IS) (130.17 KB - PDF)
italiano (IT) (138.65 KB - PDF)
latviešu valoda (LV) (186.9 KB - PDF)
lietuvių kalba (LT) (131.19 KB - PDF)
magyar (HU) (133.33 KB - PDF)
Malti (MT) (161.98 KB - PDF)
Nederlands (NL) (136.66 KB - PDF)
norsk (NO) (136.75 KB - PDF)
polski (PL) (203.14 KB - PDF)
português (PT) (174.2 KB - PDF)
română (RO) (202.67 KB - PDF)
slovenčina (SK) (209.19 KB - PDF)
slovenščina (SL) (193.19 KB - PDF)
Suomi (FI) (127.3 KB - PDF)
svenska (SV) (155.16 KB - PDF)